Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tocilizumab biosimilar
BIOLOGICAL
2 trials
Sponsors
Merck Sharp & Dohme LLC
Conditions
Chronic Lymphocytic Leukaemia
Endometrial Neoplasms
Hematologic Malignancies
Ovarian Neoplasms
Small Lymphocytic Lymphoma
Phase 1
A Clinical Trial of MK-6255 to Treat Endometrial and Ovarian Cancer (MK-6255-001)
Not yet recruiting
NCT07870278
Merck Sharp & Dohme LLC
Ovarian Neoplasms, Endometrial Neoplasms
Start: 2026-11-13
End: 2031-07-07
Target: 80
Updated: 2026-10-13
Phase 2
A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)
Not yet recruiting
NCT07709000
Merck Sharp & Dohme LLC
Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Hematologic Malignancies
Start: 2026-10-09
End: 2033-11-16
Target: 60
Updated: 2026-10-08